A developing portrait of hereditary periodic fevers in childhood

References

• Manthiram K, Zhou Q, Aksentijevich I, et al. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol. 2017 Jul 19;18(8):832–842.
   PubMed Web of Science ®Google Scholar
• Rigante D. Autoinflammatory syndromes behind the scenes of recurrent fevers in children. Med Sci Monit. 2009 Aug;15(8):RA179–187.
   PubMed Web of Science ®Google Scholar
• Caso F, Cantarini L, Lucherini OM, et al. Working the endless puzzle of hereditary autoinflammatory disorders. Mod Rheumatol. 2014 May;24(3):381–389.
   PubMed Web of Science ®Google Scholar
• de Torre-Minguela C, Mesa Del Castillo P, Pelegrín P. The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases. Front Immunol. 2017 Jan;27(8):43.
   Google Scholar
• Lopalco G, Cantarini L, Vitale A, et al. Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives. Mediators Inflamm. 2015;2015:194864.
   PubMed Web of Science ®Google Scholar
• Rigante D. The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmun Rev. 2012 Mar;11(5):348–356.
   PubMed Web of Science ®Google Scholar
• Rigante D. A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner. Expert Rev Clin Immunol. 2017 Jun;13(6):571–597.
   PubMed Web of Science ®Google Scholar
• Rigante D, Frediani B, Galeazzi M, et al. From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases. Biomed Res Int. 2013;2013:485103.
   PubMed Web of Science ®Google Scholar
• Pras M. Familial Mediterranean fever: from the clinical syndrome to the cloning of the pyrin gene. Scand J Rheumatol. 1998;27(2):92–97.
   PubMed Web of Science ®Google Scholar
• Sohar E, Gafni J, Pras M, et al. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967 Aug;43(2):227–253.
   PubMed Web of Science ®Google Scholar
• Park YH, Wood G, Kastner DL, et al. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol. 2016 Aug;17(8):914–921.
   PubMed Web of Science ®Google Scholar
• Touitou I, Sarkisian T, Medlej-Hashim M, et al. Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum. 2007 May;56(5):1706–1712.
   PubMedGoogle Scholar
• Ben-Chetrit E, Touitou I. Familial Mediterranean fever in the world. Arthritis Rheum. 2009 Oct 15;61(10):1447–1453.
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997 Oct;40(10):1879–1885.
   PubMed Web of Science ®Google Scholar
• Guz G, Kanbay M, Ozturk MA. Current perspectives on familial Mediterranean fever. Curr Opin Infect Dis. 2009 Jun;22(3):309–315.
   PubMed Web of Science ®Google Scholar
• Rigante D, La Torraca I, Avallone L, et al. The pharmacological basis of treatment with colchicine in children with familial Mediterranean fever. Eur Rev Med Pharmacol Sci. 2006 Jul-Aug;10(4):173–178.
   PubMedGoogle Scholar
• Mimouni A, Magal N, Stoffman N, et al. Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics. 2000 May;105(5):E70.
   PubMed Web of Science ®Google Scholar
• Rigante D, Manna R. A position for tumor necrosis factor inhibitors in the management of colchicine-resistant familial Mediterranean fever? Immunol Lett. 2016;180:77–78.
   PubMed Web of Science ®Google Scholar
• Ozen S, Koné-Paut I, Gül A. Colchicine resistance and intolerance in familial Mediterranean fever: definition, causes, and alternative treatments. Semin Arthritis Rheum. 2017 Aug;47(1):115–120.
   PubMed Web of Science ®Google Scholar
• Stojanov S, McDermott MF. The tumour necrosis factor receptor-associated periodic syndrome: current concepts. Expert Rev Mol Med. 2005 Oct 10;7(22):1–18.
   PubMedGoogle Scholar
• Rigante D, Lopalco G, Vitale A, et al. Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome. Clin Rheumatol. 2014 Sep;33(9):1197–1207.
   PubMed Web of Science ®Google Scholar
• Aksentijevich I, Galon J, Soares M, et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet. 2001 Aug;69(2):301–314.
   PubMed Web of Science ®Google Scholar
• Rigante D, Cantarini L, Imazio M, et al. Autoinflammatory diseases and cardiovascular manifestations. Ann Med. 2011 Aug;43(5):341–346.
   PubMed Web of Science ®Google Scholar
• Rigante D, Vitale A, Lucherini OM, et al. The hereditary autoinflammatory disorders uncovered. Autoimmun Rev. 2014 Sep;13(9):892–900.
   PubMed Web of Science ®Google Scholar
• Cantarini L, Rigante D, Brizi MG, et al. Clinical and biochemical landmarks in systemic autoinflammatory diseases. Ann Med. 2012 Nov;44(7):664–673.
   PubMed Web of Science ®Google Scholar
• Jesus AA, Oliveira JB, Aksentijevich I, et al. TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept. Eur J Pediatr. 2008 Dec;167(12):1421–1425.
   PubMed Web of Science ®Google Scholar
• Rigante D. Tumor necrosis factor inhibitors in tumor necrosis factor receptor-associated periodic syndrome: still a chance to work? Intern Emerg Med. 2017 Mar;12(2):269–270.
   PubMed Web of Science ®Google Scholar
• Vitale A, Rigante D, Lucherini OM, et al. Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm. 2013;2013:939847.
   PubMed Web of Science ®Google Scholar
• van der Meer JW, Vossen JM, Radl J, et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet. 1984 May 19;1(8386):1087–1090.
   PubMed Web of Science ®Google Scholar
• ter Haar NM, Jeyaratnam J, Lachmann HJ, et al. The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever registry. Arthritis Rheumatol. 2016 Nov;68(11):2795–2805.
   PubMed Web of Science ®Google Scholar
• Simon A, Kremer HP, Wevers RA, et al. Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology. 2004 Mar 23;62(6):994–997.
   PubMed Web of Science ®Google Scholar
• Rigante D, Lopalco G, Vitale A, et al. Untangling the web of systemic autoinflammatory diseases. Mediators Inflamm. 2014;2014:948154.
   PubMed Web of Science ®Google Scholar
• Caso F, Rigante D, Vitale A, et al. Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol. 2013;2013:513782.
   PubMedGoogle Scholar
• van der Hilst JC, Bodar EJ, Barron KS, et al. Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore). 2008 Nov;87(6):301–310.
   PubMed Web of Science ®Google Scholar
• de Pieri C, Taddio A, Insalaco A, et al. Different presentations of mevalonate kinase deficiency: a case series. Clin Exp Rheumatol. 2015 May-Jun;3(3):437–442.
   Google Scholar
• Esposito S, Ascolese B, Senatore L, et al. Current advances in the understanding and treatment of mevalonate kinase deficiency. Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):491–498.
   PubMed Web of Science ®Google Scholar
• Neven B, Prieur AM, Quartier dit Maire P. Cryopyrinopathies: update on pathogenesis and treatment. Nat Clin Pract Rheumatol. 2008 Sep;4(9):481–489.
   PubMedGoogle Scholar
• Cantarini L, Lucherini OM, Frediani B, et al. Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes. Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):827–836.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Lowe P, Felix SD, et al. In vivo regulation of interleukin 1-beta in patients with cryopyrin-associated periodic syndromes. J Exp Med. 2009 May 11;206(5):1029–1036.
   PubMed Web of Science ®Google Scholar
• Aksentijevich I, D Putnam C, Remmers EF, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007 Apr;56(4):1273–1285.
   PubMed Web of Science ®Google Scholar
• Kubota T, Koike R. Cryopyrin-associated periodic syndromes: background and therapeutics. Mod Rheumatol. 2010 Jun;20(3):213–221.
   PubMed Web of Science ®Google Scholar
• Sarrabay G, Grandemange S, Touitou I. Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts. Expert Rev Clin Immunol. 2015;11(7):827–835.
   PubMed Web of Science ®Google Scholar
• Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, et al. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS). Ann Rheum Dis. 2017 Jun;76(6):942–947.
   PubMed Web of Science ®Google Scholar
• Omoyinmi E, Melo Gomes S, Standing A, et al. Brief report: whole-exome sequencing revealing somatic NLRP3 mosaicism in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheumatol. 2014 Jan;66(1):197–202.
   PubMed Web of Science ®Google Scholar
• Neven B, Marvillet I, Terrada C, et al. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum. 2010 Jan;62(1):258–267.
   PubMed Web of Science ®Google Scholar
• Rigante D, Ansuini V, Caldarelli M, et al. Hydrocephalus in CINCA syndrome treated with anakinra. Childs Nerv Syst. 2006 Apr;22(4):334–337.
   PubMed Web of Science ®Google Scholar
• Federico G, Rigante D, Pugliese AL, et al. Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome. Scand J Rheumatol. 2003;32(5):312–314.
   PubMed Web of Science ®Google Scholar
• Landmann EC, Walker UA. Pharmacological treatment options for cryopyrin-associated periodic syndromes. Expert Rev Clin Pharmacol. 2017 Aug;10(8):855–864.
   PubMed Web of Science ®Google Scholar
• Jéru I, Duquesnoy P, Fernandes-Alnemri T, et al. Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci USA. 2008 Feb 5;105(5):1614–1619.
   PubMed Web of Science ®Google Scholar
• Vitale A, Rigante D, Maggio MC, et al. Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):155–156.
   PubMed Web of Science ®Google Scholar
• Tallon B, Corkill M. Peculiarities of PAPA syndrome. Rheumatology. 2006 Sep;45(9):1140–1143.
   PubMed Web of Science ®Google Scholar
• Löffler W, Lohse P, Weihmayr T, et al. Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial cell counts. Infection. 2017 Aug;45(4):395–402.
   PubMed Web of Science ®Google Scholar
• Niv D, Ramirez JA, Fivenson DP. Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis. JAAD Case Rep. 2017 Feb 4;3(1):70–73.
   PubMedGoogle Scholar
• Schellevis MA, Stoffels M, Hoppenreijs EP, et al. Variable expression and treatment of PAPA syndrome. Ann Rheum Dis. 2011 Jun;70(6):1168–1170.
   PubMed Web of Science ®Google Scholar
• Ferguson PJ, Chen S, Tayeh MK, et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet. 2005 Jul;42(7):551–557.
   PubMed Web of Science ®Google Scholar
• Aksentijevich I, Masters SL, Ferguson PJ, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009 Jun 4;360(23):2426–2437.
   PubMed Web of Science ®Google Scholar
• Masters SL, Lagou V, Jéru I, et al. Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation. Sci Transl Med. 2016 Mar 30;8(332):332ra45.
   PubMed Web of Science ®Google Scholar
• Okafuji I, Nishikomori R, Kanazawa N, et al. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum. 2009 Jan;60(1):242–250.
   PubMed Web of Science ®Google Scholar
• Borzutzky A, Fried A, Chou J, et al. NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin Immunol. 2010 Mar;134(3):251–261.
   PubMed Web of Science ®Google Scholar
• Caso F, Costa L, Rigante D, et al. Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev. 2014 Dec;13(12):1220–1229.
   PubMed Web of Science ®Google Scholar
• Rosé CD, Pans S, Casteels I, et al. Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes. Rheumatology (Oxford). 2015 Jun;54(6):1008–1016.
   PubMed Web of Science ®Google Scholar
• Jordan CT, Cao L, Roberson ED, et al. Rare and common variants in CARD14, encoding an epidermal regulator of NF-κB, in psoriasis. Am J Hum Genet. 2012 May 4;90(5):796–808.
   PubMed Web of Science ®Google Scholar
• Marrakchi S, Guigue P, Renshaw BR, et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med. 2011 Aug 18;365(7):620–628.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Yu X, Demirkaya E, et al. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10127–10132.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ramot Y, Torrelo A, et al. Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity. Arthritis Rheumatol. 2012 Mar;64(3):895–907.
   PubMed Web of Science ®Google Scholar
• Cavalcante MP, Brunelli JB, Miranda CC, et al. CANDLE syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature-a rare case with a novel mutation. Eur J Pediatr. 2016 May;175(5):735–740.
   PubMed Web of Science ®Google Scholar
• McDermott A, Jacks J, Kessler M, et al. Proteasome-associated autoinflammatory syndromes: advances in pathogeneses, clinical presentations, diagnosis, and management. Int J Dermatol. 2015 Feb;54(2):121–129.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jesus AA, Marrero B, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014 Aug 7;371(6):507–518.
   PubMed Web of Science ®Google Scholar
• Tarantino G, Esposito S, Andreozzi L, et al. Lung involvement in children with hereditary autoinflammatory disorders. Int J Mol Sci. 2016 Dec 15;17(12):2111.
   Web of Science ®Google Scholar
• Zhou Q, Yang D, Ombrello AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014 Mar 6;370(10):911–920.
   PubMed Web of Science ®Google Scholar
• Rigante D, Esposito S. A roadmap for fever of unknown origin in children. Int J Immunopathol Pharmacol. 2013 Apr-Jun;26(2):315–326.
   PubMed Web of Science ®Google Scholar
• Cantarini L, Lopalco G, Cattalini M, et al. Interleukin-1: ariadne’s thread in autoinflammatory and autoimmune disorders. Isr Med Assoc J. 2015 Feb;17(2):93–97.
   PubMed Web of Science ®Google Scholar
• Stabile A, Bertoni B, Ansuini V, et al. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. Eur Rev Med Pharmacol Sci. 2006 Mar-Apr;10(2):53–59.
   PubMedGoogle Scholar
• Rigante D, Emmi G, Fastiggi M, et al. Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol. 2015 Aug;34(8):1333–1339.
   PubMed Web of Science ®Google Scholar
• Cantarini L, Lucherini OM, Iacoponi F, et al. Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders. Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1133–1141.
   PubMed Web of Science ®Google Scholar
• Ter Haar NM, Annink KV, Al-Mayouf SM, et al. Development of the autoinflammatory disease damage index (ADDI). Ann Rheum Dis. 2017 May;76(5):821–830.
   PubMed Web of Science ®Google Scholar